WEIGHT LOSS DRUGS MAY HELP TREAT KIDNEY DISEASE.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    AARP Bulletin. Jul/Aug2024, Vol. 65 Issue 6, p6-6. 1/5p.
  • Additional Information
    • Subject Terms:
      ANTIOBESITY agents; KIDNEY diseases; TYPE 2 diabetes; SEMAGLUTIDE; DISEASE risk factors
    • Abstract:
      A recent study published in The New England Journal of Medicine found that the medication found in diabetes and weight loss drugs Ozempic and Wegovy can significantly reduce the risk of kidney complications in individuals with type 2 diabetes and chronic kidney disease. The drug's manufacturer, Novo Nordisk, plans to petition the U.S. Food and Drug Administration to allow the drug to be prescribed for this purpose. However, experts caution against using these drugs without consulting a doctor or obtaining a prescription. The FDA also warns against purchasing these drugs online, as they may be illegally marketed and potentially harmful. [Extracted from the article]
    • Abstract:
      Copyright of AARP Bulletin is the property of AARP and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)